The US Meals and Drug Administration has authorised Cobenfy, which is owned by pharmaceutical agency Bristol Myers Squibb.
Supply hyperlink
New schizophrenia drug ‘might change the lives of tens of millions of individuals’
The US Meals and Drug Administration has authorised Cobenfy, which is owned by pharmaceutical agency Bristol Myers Squibb.
Supply hyperlink
